Lori Beth Racha, MD in Burlington, VT - Medicare Pediatrics

Lori Beth Racha, MD is a medicare enrolled "Pediatrics" physician in Burlington, Vermont. Her current practice location is 1 S Prospect St, Burlington, Vermont. You can reach out to her office (for appointments etc.) via phone at (802) 847-4696.

Lori Beth Racha is licensed to practice in Vermont (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1447272869.

Contact Information

	Lori Beth Racha, MD
	1 S Prospect St, Burlington, VT 05401-3456
	(802) 847-4696
	Not Available

Physician's Profile

Full Name	Lori Beth Racha
Gender	Female
Speciality	Pediatrics
Location	1 S Prospect St, Burlington, Vermont
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1447272869
Provider Enumeration Date: 07/24/2006
Last Update Date: 07/09/2007

Medicare PECOS Information:

PECOS PAC ID: 8729037080
Enrollment ID: I20050113000931

Medical Identifiers

Medical identifiers for Lori Beth Racha such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447272869	NPI	-	NPPES
VT1010923	Medicaid	VT

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	(Vermont)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Lori Beth Racha allows following entities to bill medicare on her behalf.

Entity Name	University Of Vermont Medical Center Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047

News Archive

World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that its dengue vaccine is in final stage of clinical development. Sanofi Pasteur's dengue vaccine, the world's most clinically advanced dengue vaccine candidate, entered its first phase 3 clinical study in Australia.

Pear, VeraLight partner to distribute SCOUT DS device in pharmacies across Canada

VeraLight Inc., the first company to develop an optical skin measurement for noninvasive diabetes screening, and Pear Healthcare Solutions Inc., a leading provider of in-pharmacy health screening and education services, today announced an agreement for the distribution of the SCOUT DS device in pharmacies across Canada.

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Emmaus Medical, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of innovative and cost-effective treatments and therapies primarily for rare and orphan diseases, today announced it has completed all patient visits for its Phase 3 clinical trial for the treatment of sickle cell disease. Emmaus expects top-line data from the Phase 3 clinical trial to be available in the first quarter of 2014.

New compounds for the treatment of HIV/AIDS

Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lori Beth Racha is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lori Beth Racha, MD 190 Hinesburg Rd, Charlotte, VT 05445-9378 Ph: (802) 425-3771	Lori Beth Racha, MD 1 S Prospect St, Burlington, VT 05401-3456 Ph: (802) 847-4696

News Archive

World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

Pear, VeraLight partner to distribute SCOUT DS device in pharmacies across Canada

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

New compounds for the treatment of HIV/AIDS

Pediatrics Doctors in Burlington, VT

Anisha Rimal, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000
Dr. William Raszka, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 Fax: 802-847-8742
Dr. Valerie J. Riss, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave., C/o Uvm Medical Center, Children's/pedi-hospitalists, Burlington, VT 05401 Phone: 802-847-2700
Dr. Nancy A Drucker, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 Fax: 802-847-8742
Dr. Nilgun Tapucu Zimakas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4696 Fax: 902-847-4612
Dr. Joseph Francis Hagan Jr., M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 128 Lakeside Ave, Suite 115, Burlington, VT 05401 Phone: 802-860-1928
Dr. Elizabeth Duncan Ulano, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave., Uvm Medical Center, Children's/picu, Burlington, VT 05401 Phone: 802-847-2304 Fax: 802-847-0258

Lori Beth Racha, MD - Medicare Pediatrics in Burlington, VT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

Pear, VeraLight partner to distribute SCOUT DS device in pharmacies across Canada

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

New compounds for the treatment of HIV/AIDS

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

Pear, VeraLight partner to distribute SCOUT DS device in pharmacies across Canada

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

New compounds for the treatment of HIV/AIDS

Pediatrics Doctors in Burlington, VT